Could stem cell vesicles treat spinal cord cavities?
NCT ID NCT07295067
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This early-stage trial tests whether injections of tiny particles from umbilical cord stem cells are safe for people with syringomyelia, a condition where fluid-filled cavities form in the spinal cord. The study will enroll 18 adults whose symptoms haven't improved after surgery or natural shrinkage of the cavity. Participants receive three monthly injections into the spinal fluid, and researchers will monitor for side effects and any changes in spinal cord function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- extracellular vesicles from human umbilical cord blood mesenchymal stem cells
- What this could lead to
- If safe and effective, this could point toward a new treatment option for syringomyelia that may improve spinal cord function.
- What could go wrong
- This is a very early Phase 1 trial with only 18 participants, focused on safety. It may not show clear benefit, and there are risks of serious side effects from the injections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYRINGOMYELIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuanwu Hospital
Beijing, Beijing City, 100032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.